Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Ironwood Pharmaceuticals, Inc. (IRWD) had Receiveable Turnover of 3.43 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$442.74M |
|
$-1.00B |
|
-- |
|
$442.74M |
|
$1.39B |
|
$-945.43M |
|
$-2.64M |
|
$-948.07M |
|
$-948.09M |
|
$-1.03B |
|
$-1.03B |
|
$-1.03B |
|
$-1.03B |
|
$-945.43M |
|
$-943.86M |
|
155.44M |
|
155.44M |
|
$-6.45 |
|
$-6.45 |
|
| Balance Sheet Financials | |
$233.29M |
|
$5.58M |
|
$237.78M |
|
$471.07M |
|
$276.10M |
|
$498.31M |
|
$541.27M |
|
$817.37M |
|
$-346.30M |
|
$-349.98M |
|
$-346.30M |
|
156.35M |
|
| Cash Flow Statement Financials | |
$183.43M |
|
$-1.03B |
|
$277.16M |
|
$657.94M |
|
$92.15M |
|
$-565.78M |
|
$32.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.84 |
|
-- |
|
-- |
|
3.28 |
|
-2.02 |
|
100.00% |
|
-213.54% |
|
-213.54% |
|
-213.19% |
|
-214.14% |
|
-226.37% |
|
$183.15M |
|
-- |
|
-- |
|
-- |
|
0.94 |
|
-- |
|
|
Receiveable Turnover |
3.43 |
106.45 |
|
297.88% |
|
294.75% |
|
-218.98% |
|
-678.59% |
|
$-2.21 |
|
$1.18 |
|
$1.18 |
|